Market Research Report

Vietnam Diagnostic Tests Market Research Report: Forecast (2025-2030)

Diagnostic Tests Market in Vietnam - By Product Type (Immunoassay-Based Diagnostic Tests, Molecular Diagnostic Tests, Clinical Chemistry Diagnostic Tests, Hematology Diagnostic Tes...ts, Microbiology Diagnostic Tests, Rapid/Point-of-Care Diagnostic Tests, Others), By End Users (Hospital-Based Laboratories, Diagnostic Centers/Stand-alone Labs, Clinics, Home Care, Research Institutes) and Others Read more

  • Healthcare
  • Jul 2025
  • Pages 128
  • Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Market Insights & Analysis: Vietnam Diagnostic Tests Market (2025-30):

The Vietnam Diagnostic Tests Market size was valued at around USD 1.84 billion in 2024 and is expected to reach USD 6.79 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 24.31% during the forecast period, i.e., 2025-30. The Vietnam Diagnostic Tests Market is significantly growing due to several growth factors, including the high incidence of chronic diseases, like cardiovascular diseases, kidney disorders, diabetes, hypertension, infectious diseases, and many more in the country, the rising government support through significant investments, the rapid shift towards digitalization, the adoption of technological advancement like AI with the diagnostic tools and software, etc. One of the major growth factors is the rising public awareness about early disease detection for better treatments is increasing the number of regular checkups and screenings, thus uplifting the market size & volume.

Report Coverage Details
Historical Years 2020–23
Base Years 2024
Forecast Years 2025–30
Market Value in 2024 USD 1.84 Billion
Market Value by 2030 USD 6.79 Billion
CAGR (2025–30) 24.31%
Top Key Players Roche Vietnam Co., Ltd., Siemens Healthineers (Vietnam) Co., Ltd., Abbott Laboratories S.A. (Vietnam), Danaher Corporation (Beckman Coulter Vietnam), Becton, Dickinson and Company (BD Vietnam), Thermo Fisher Scientific (Vietnam), Bio-Rad Laboratories (Vietnam), Medtronic Vietnam, Viet A Corporation, Medicon Co., Ltd, Sao Thai Duong Joint Stock Company, and others
Segmentation By Product Type (Immunoassay-Based Diagnostic Tests, Molecular Diagnostic Tests, Clinical Chemistry Diagnostic Tests, Hematology Diagnostic Tests, Microbiology Diagnostic Tests, Rapid/Point-of-Care Diagnostic Tests, Others), By End Users (Hospital-Based Laboratories, Diagnostic Centers/Stand-alone Labs, Clinics, Home Care, Research Institutes) and Others
Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation
  • Recent Strategic Moves by Companies
  • Primary Stakeholders
  • Import/Export Trend Analysis
  • Competitive Landscape Assessment
  • Emerging Opportunities
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the Vietnamese government is actively supporting the market growth by heavily investing in the expansion of the healthcare infrastructure and the medical device industry in the country. These substantial funds are allocated by the government through various policies, such as the National Strategy for Healthcare Development under Vision 2045, the National Pharmaceutical Industry Strategy, the Law of Health Insurance & law on Pharmacy, and the Law on Medical Examination & Treatment. Such kind of support offers ample growth opportunities for this market to grow further. Moreover, the adoption of artificial intelligence in the healthcare industry and the rising inclination towards digitalization are actively transforming the market. However, the high cost of the diagnostic tests and the limited infrastructure are restraining the market growth & expansion.

Vietnam Diagnostic Tests Market Driver:

Rising Prevalence of Chronic Diseases Driving Market Growth – The high incidence of chronic diseases, like diabetes, cardiovascular disease, cancer, respiratory diseases, kidney disorders, liver disease, and many more in the country, is driving the market growth. For instance, in 2024, approximately 7 million Vietnamese citizens were diagnosed with diabetes. Similarly, as of 2024, around 12 million people in the country are living with hypertension, contributing to the market growth.

Additionally, every year, almost 2,00,000 new cancer cases are added in the country, which is confirmed by various diagnostic tests such as biopsies, molecular diagnostics, etc., thus increasing the market demand. Also, the major cause of death in Vietnam is the high prevalence of cardiovascular diseases, which is responsible for about 30% of the total deaths per year. Moreover, about 12% of the country’s population has chronic kidney disease as of 2024. Likewise, the high prevalence of many other chronic diseases is increasing the diagnostic testing market in the country.


Vietnam Diagnostic Tests Market growth trends (2025-2030)

Vietnam Diagnostic Tests Market Opportunity:

Increasing Government Support in the Healthcare Industry – The rising support of the national government in the healthcare industry is offering ample growth opportunities for the market. This includes the implementation of various policies and heavy investments in the expansion of the manufacturing units for medical diagnostic devices. For instance, in 2024, the Vietnamese government introduced the law on medical examination and treatment, which mandates the electronic health records and prescriptions to the health department for improving the healthcare facilities and increasing the diagnostics industry in the country.

Additionally, the National Strategy for Healthcare Development under Vision 2045, the government is allocating significant funds for the development of diagnostic centers in the country. For example, in 2024, the Thong Nath Hospital inaugurated a high-tech diagnostic center equipped with Spectral CT 7500, 3 Tesla MRI, and digital subtraction angiography in Ho Chi Minh City. Moreover, the Ministry of Health is planning to upgrade six provincial testing centers to regional testing centers to increase diagnostic accessibility. These efforts are increasing the potential market growth.

Vietnam Diagnostic Tests Market Challenge:

Limited Infrastructure & High Costs – The hospitals, especially in rural and remote areas of the country, lack suitable infrastructure for the establishment of advanced diagnostic machinery, thus hindering the market growth. Out of these facilities, several hospitals are still relying on the outdated diagnostic tools, including X-ray machines for diagnostic purposes, thus hindering the market growth & expansion.

Additionally, the diagnostic tests are costly, which puts a financial barrier to a major population in the country and limits the market growth. For instance, the MRI machines cost about USD3 million. Similarly, a single PCR test can cost up to USD50, while that of biopsies is approximately USD150. Also, the biopsy costs exceed USD300 in Vietnam. These are negatively impacting the diagnostic tests market, thus restraining the market growth.

Vietnam Diagnostic Tests Market Trend:

Digital Health & AI-Powered Diagnostics Gaining Traction – Market dynamics are changing positively due to the rapid shift towards digital healthcare facilities and the integration of advanced technologies such as machine learning and artificial intelligence in diagnostic tools & machines. These tests provide better results with high efficiency and faster patient outcomes over traditional diagnostics.

Several companies, such as VinBrain, Vikomed, FPT Software, TMA, etc., are introducing advanced diagnostic tests that are integrated with digitalization and artificial intelligence. For instance, VinBrain introduced DrAid™ AI Platform, which is developed to enhance healthcare delivery, especially in diagnostic imaging. This system has already been deployed in almost 182 hospitals in the country. Also, VinBrain rolled out AI-based TB screening using chest X-rays at scale. This innovation reduces screening costs from approximately USD50–60 to just USD1 per patient, with results delivered in under 20 seconds. These innovations are actively transforming the Vietnam Diagnostic Tests Market.

Vietnam Diagnostic Tests Market (2025-30): Segmentation Analysis

The Vietnam Diagnostic Tests Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Product Type:

  • Immunoassay-Based Diagnostic Tests
  • Molecular Diagnostic Tests
  • Clinical Chemistry Diagnostic Tests
  • Hematology Diagnostic Tests
  • Microbiology Diagnostic Tests
  • Rapid/Point-of-Care Diagnostic Tests
  • Others

Among these, immunoassay-based diagnostic tests are the leading product type and hold about 30% market share. The dominance is due to the high accuracy and quick results of these tests over other tests; therefore, people are preferring for the immuno-based diagnostic tests in the country. One of the major growth factors of this type of test is the rising prevalence of diseases like TB, hepatitis B & C, HIV, etc. in Vietnam, as these tests must be accurate and faster for early and precise treatment.

Additionally, these tests are cheaper and sensitive, thus increasing the demand. For instance, the SARS-CoV-2 Antigen Tests are just USD7.8 per test, which is under budget for a large group of customers, thus dominating the market segment. It has led to increased affordability, including in rural and remote areas, and accessibility due to its small and compact size.

Based on End-Users:

  • Hospital-Based Laboratories
  • Diagnostic Centers/Stand-alone Labs
  • Clinics
  • Home Care
  • Research Institutes
  • Others

Out of these, the hospital-based laboratories are dominating the market with a market share of around 50%. The dominance is due to the analysis of a large volume of patients in a smaller period, which is creating the demand for advanced imaging technologies for urology, gynecology, cardiology, etc., thus leading the market segment.

Additionally, the government healthcare policies in Vietnam are increasing the infrastructural development of healthcare in the country, including the establishment of diagnostic machinery and equipment in the hospitals. Also, the large infrastructure in hospitals is providing adequate space to set up big size diagnostic machinery such as CT scans, MRI machines, biopsy labs, etc. These factors are contributing to the dominance of hospital-based laboratories in the market.

Vietnam Diagnostic Tests Industry Recent Development:

  • 2024: Siemens Healthineers supported the opening of CarePlus Imaging Center in Ho Chi Minh City, supplying AI-integrated MAGNETOM Sempra MRI and SOMATOM go. All CT systems are to enhance diagnostic precision in oncology, cardiovascular, and neurological screening.
  • 2024: Roche Vietnam Co., Ltd., on its 30th anniversary, plans to launch new ophthalmology diagnostic technologies in Vietnam, aiming to improve early detection and treatment of serious eye diseases.

Gain a Competitive Edge with Our Vietnam Diagnostic Tests Market Report

  1. Vietnam Diagnostic Tests Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  3. Vietnam Diagnostic Tests Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Frequently Asked Questions

   A. The Vietnam Diagnostic Tests Market is expected to grow at a compound annual growth rate (CAGR) of around 24.31% over the forecast period.

   A. The Vietnam Diagnostic Tests Market size was valued at around USD1.84 billion in 2024 and is expected to reach USD6.79 billion by 2030.

   A. The rising prevalence of chronic diseases is expected to drive the Vietnam Diagnostic Tests Market during 2025-30.

   A. Roche Vietnam Co., Ltd., Siemens Healthineers (Vietnam) Co., Ltd., Abbott Laboratories S.A. (Vietnam), Danaher Corporation (Beckman Coulter Vietnam), Becton, Dickinson and Company (BD Vietnam), Thermo Fisher Scientific (Vietnam), Bio-Rad Laboratories (Vietnam), Medtronic Vietnam, Viet A Corporation, Medicon Co., Ltd, Sao Thai Duong Joint Stock Company, and others are the top companies in the Vietnam Diagnostic Tests Market.

   A. Immunoassay-based diagnostic tests held the largest share of the Vietnam Diagnostic Tests Market.

   A. The increasing popularity of digital health & AI-powered diagnostics is one of the key trends shaping the growth of the Vietnam Diagnostic Tests Market.

   A. Increasing government support in the healthcare industry is one of the growth opportunities driving the Vietnam Diagnostic Tests Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Vietnam Diagnostic Tests Market Policies, Regulations, and Product Standards
  5. Vietnam Diagnostic Tests Market Supply Chain Analysis
  6. Vietnam Diagnostic Tests Market Trends & Developments
  7. Vietnam Diagnostic Tests Market Dynamics
    1. Growth Drivers
    2. Challenges
  8. Vietnam Diagnostic Tests Market Hotspot & Opportunities
  9. Vietnam Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By Product Type
          1. Immunoassay-Based Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          2. Molecular Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          3. Clinical Chemistry Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          4. Hematology Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          5. Microbiology Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          6. Rapid/Point-of-Care Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
          7. Others
        2. By End Users
          1. Hospital-Based Laboratories- Market Size & Forecast 2020–2030, USD Million
          2. Diagnostic Centers/Stand-alone Labs- Market Size & Forecast 2020–2030, USD Million
          3. Clinics- Market Size & Forecast 2020–2030, USD Million
          4. Home Care- Market Size & Forecast 2020–2030, USD Million
          5. Research Institutes- Market Size & Forecast 2020–2030, USD Million
          6. Others
        3. By Region
          1. Northern
          2. Central
          3. Southern
          4. Southeast
          5. Mekong Delta
        4. By Company
          1. Company Revenue Shares
          2. Competitor Characteristics
  10. Vietnam Immunoassay-Based Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By Distribution End Users - Market Size & Forecast 2020–2030, USD Million
  11. Vietnam Molecular Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By End Users - Market Size & Forecast 2020–2030, USD Million
  12. Vietnam Clinical Chemistry Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By End Users - Market Size & Forecast 2020–2030, USD Million
  13. Vietnam Hematology Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By End Users - Market Size & Forecast 2020–2030, USD Million
  14. Vietnam Microbiology Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By End Users - Market Size & Forecast 2020–2030, USD Million
  15. Vietnam Rapid/Point-of-Care Diagnostic Tests Market Outlook, 2020–2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units)
        1. By End-Users - Market Size & Forecast 2020–2030, USD Million
  16. Vietnam Diagnostic Tests Market Key Strategic Imperatives for Success & Growth
  17. Competition Outlook
    1. Company Profiles
      1. Roche Vietnam Co., Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Siemens Healthineers (Vietnam) Co., Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Abbott Laboratories S.A. (Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Danaher Corporation (Beckman Coulter Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Becton, Dickinson and Company (BD Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Thermo Fisher Scientific (Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Bio-Rad Laboratories (Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Medtronic Vietnam
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Viet A Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Medicon Co., Ltd
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Sao Thai Duong Joint Stock Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making